期刊文献+

生长激素促分泌物受体的内源性配体ghrelin促进大鼠心肌微血管内皮细胞体外血管生成 被引量:10

Ghrelin stimulates in vitro angiogenic capacity of rat cardiac microvascular endothelial cells
原文传递
导出
摘要 目的 探讨生长激素促分泌物受体的内源性配体 ghrelin 对大鼠心肌微血管内皮细胞增殖、迁移和体外血管生成的影响,并探讨其潜在的信号转导途径.方法 (1)植块法分离成年SD 雄性大鼠的心肌微血管内皮细胞,Ⅷ因子免疫组织化学鉴定细胞种类并传代培养.(2)通过逆转录聚合酶链反应(RT-PCR)、免疫荧光、酶联免疫吸附试验(ELISA)、免疫印迹法(Western blot)鉴定ghrelin及其天然受体(growth hormone secretagogue-receptor,GHS-R)在心肌微血管内皮细胞上mRNA 及蛋白的表达.(3)用不同浓度(10-9~10-7mol/L)的ghrelin干预心肌微血管内皮细胞后,检测心肌微血管内皮细胞的增殖、迁移及体外血管生成的变化.(4)用不同浓度(10-9~10-7 mol/L)的ghrelin 干预心肌微血管内皮细胞后,观察ERK2磷酸化表达.用MAPK/ERK2的特异性抑制剂PD98059提前干预细胞后,观察ghrelin对大鼠心肌微血管内皮细胞体外血管生成及ERK2磷酸化表达的变化.结果 (1)植块法培养的原代心肌微血管肉皮细胞纯度达95%左右,且具有形成管腔样结构的能力.(2)RT-PCR、免疫荧光、ELISA和Western blot检测发现ghrelin及GHS-R在心肌微血管内皮细胞上均有表达.(3)分别用10-9~10-7 mol/L的ghrelin干预心肌微血管内皮细胞后,发现10-8、10-7 mol/L ghrelin处理组心肌微血管内皮细胞的增殖明显高于正常对照组[分别为(12.37±0.70)和(12.73±0.78)pmol/L比(7.40±0.71)pmol/L,P值均为0.001],迁移亦明显高于正常对照组(分别为127.00±4.06和121.00±4.30比113.80±4.60,p值分别为0.001和0.03),体外的血管生成亦明显高于正常对照组[分别为(72.20±5.72)和(71.00±7.78)mm比(28.60±5.13)mm,P均<0.001].(4)10-8、10-7mol/L ghrelin处理组ERK2的磷酸化表达水平明显高于正常对照组(分别为0.92±0.13和1.15 ±0.16比0.29±0.04,P均<0.001).若提前用PD98059干预细胞,则能明显抑制ghrelin诱导的体外血管生成及ERK2的磷酸化表达.结论 ghrelin及其受体GHS-R在大鼠心肌微血管内皮细胞上均有表达,ghrelin可通过激活ERK2的磷酸化促进心肌微血管内皮细胞的体外血管生成. Objective To clarify whether ghrelin could promote in vitro rat cardiac microvascular endothelial cells(CMECs)angiogenesis and related mechanisms.Methods CMECs were isolated from myocardial tissue of adult male SD rats and characterized by the immunocytochemistry staining with Factor Ⅷ and the capacity of in vitro capillary tube-like formation.The mRNAs and protein expressions of ghrelin and its receptor(growth hormone secretagogue receptor,GHS-R)of CMECs were determined by RT-PCR,Immunofluorescence,ELISA and Western blot.Proliferation,migration and in vitro angiogenesis as well as ERK2 phosphorylation of CMECs were tested in the presence of ghrelin(10-9-10-7 mol/L)with or without pretreatment with specific MAPK/ERK2 inhibitor PD98059.Results Purity of CMECs characterized by immunocytochemistry staining with Factor Ⅷ was about 95%,and the cells showed a high ability to form the capillary tube-like structures on Matrigel.Ghrelin and GHS-R were constitutively expressed in CMECs.Proliferation,migration and in vitro angiogenesis capacities of CMECs(72.20 ±5.72 vs.28.60 ±5.13,P 〈0.001;71.00±7.78 vs.28.60 ±5.13,P 〈0.001)as well as ERK2 phosphorylation(0.92 ±0.13 vs.0.29 ± 0.04,P 〈 0.001 ; 1.15 ± 0.16 vs.0.29 ± 0.04,P 〈 0.001)were significantly enhanced by exogenous ghrelin(10-8-10-7 mol/L).PD98059 abolished ghrelin-induced ERK2 phosphorylation and in vitro angiogenesis.Conclusions Ghrelin and its receptor are expressed in CMECs and ghrelin could stimulate CMECs in vitro angiogenesis through activation of MAPK/ERK2 signaling pathway.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2012年第1期50-56,共7页 Chinese Journal of Cardiology
关键词 新生血管化 生理性 GHRELIN Neovascularization,physiologic Ghrelin
  • 相关文献

参考文献24

  • 1Matsumura K, Tsuchihashi T, Fujii K, et al. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension, 2002, 40: 694-699.
  • 2Lin Y, Matsumura K, Fukuhara M, et al. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension, 2004, 43: 977-952.
  • 3Li WG, Gavrila D, Liu X, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation, 2004, 109 : 2221-2226.
  • 4Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T ceils. J Clin Invest, 2004, 114: 57-66.
  • 5] Zhao H, Liu G, Wang Q, et al. Effect of ghrelin on human endothelial ceils apoptosis induced by high glucose. Biochem Biophys Res Commun, 2007, 362 : 677-681.
  • 6Tesauro M, Schinzari F, Iantorno M, et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation, 2005, 112 : 2986-2992.
  • 7Li A, Cheng G, Zhu GH, et al. Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release. Biochem Biophys Res Commuu, 2007, 353: 238-243.
  • 8Ahluwalia A, Li A, Cheng G, et al. Reduced ghrelin in endothelial ceils plays important mechanistic role in aging-related impairment of angiogenesis. J Physiol Pharmacol, 2009, 60 : 29- 34.
  • 9Kleinz M J, Maguire JJ, Skepper JN, et al. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoylghrelin in the regulation of vascular tone in man. Cardiovasc Res, 2006, 69: 227-235.
  • 10Katugampola SD, Pallikaros Z, Davenport AP. [ 125I-His (9)]- ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue : up-regulation of receptors with athersclerosis. Br J Pharmacol, 2001, 134: 143-149.

同被引文献94

  • 1王苹苹,孔繁平,陈学群,杜继曾.低氧细胞应激的HIF-1信号通路[J].浙江大学学报(医学版),2011,40(5):559-566. 被引量:74
  • 2Andrea Picchi,Stefano Capobianco,Marta Focardi.Coronary microvascular dysfunction in diabetes mellitus:A review[J].World Journal of Cardiology,2010,2(11):377-390. 被引量:24
  • 3张坡,黄岚,朱光旭,崔斌,宋明宝,周音频,赵晓晖,尹阳光.雷帕霉素对内皮祖细胞增殖、黏附及迁移能力影响的实验研究[J].中华心血管病杂志,2006,34(11):1021-1025. 被引量:10
  • 4Cohen G,Riahi Y,Alpert E,et al.The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes[J].Arch Physiol Biochem,2007,113:259-267.
  • 5Salminen A,Kaarniranta K.Insulin/IGF-1 paradox of aging:regulation via AKT/IKK/NF-kappaB signaling[J].Cell Signal,2010,22:573-577.
  • 6Wang J,Yang L,Yang J,et al.Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells[J].Cancer Res,2008,68:3152-3160.
  • 7李燕,张健.分子生物学实用实验技术[M].2版.西安:第四军医大学出版社,2011:206-207.
  • 8Crimi E,Ignarro LJ,Napoli C.Microcirculation and oxidative stress[J].Free Radic Res,2007,41:1364-1375.
  • 9Wei L,Sun D,Yin Z,et al.A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats[J].Apoptosis,2010,15:488-498.
  • 10Hattori R,Otani H,Maulik N,et al.Pharmacological preconditioning with resveratrol:role of nitric oxide[J].Am J Physiol Heart Circ Physiol,2002,282:H1988-H1995.

引证文献10

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部